NCT06367855 Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
| NCT ID | NCT06367855 |
| Status | Recruiting |
| Phase | Phase 4 |
| Sponsor | Potsawat Surabotsopon |
| Condition | Spinal Stenosis Lumbar |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2025-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 4 studies follow an already-approved treatment in real-world conditions to monitor long-term safety and effectiveness.
This trial targets 60 participants in total. It began in 2024-05-01 with a primary completion date of 2025-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.
Eligibility Criteria
Inclusion Criteria: * Age range: 50-80 years old. * Undergoing MIS TLIF surgery at 1-2 spinal levels. Exclusion Criteria: * Previously undergone spine surgery. * HbA1C greater than or equal to 7.5 mg% * Allergic to all types of experimental medication. * History of using systemic steroids.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06367855 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Spinal Stenosis Lumbar. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06367855 trial and what does that mean for participants?
Phase 4 studies are conducted after a treatment has been approved. They monitor long-term safety and real-world effectiveness in a broader patient population.
Is NCT06367855 currently recruiting?
Yes, NCT06367855 is actively recruiting participants. Contact the research team at gearkonthorn@gmail.com for enrollment information.
Where is the NCT06367855 trial being conducted?
This trial is being conducted at Pathum Thani, Thailand.
Who is sponsoring the NCT06367855 clinical trial?
NCT06367855 is sponsored by Potsawat Surabotsopon. The trial plans to enroll 60 participants.